These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2385876)

  • 21. Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.
    Incrocci L; Wortel RC; Alemayehu WG; Aluwini S; Schimmel E; Krol S; van der Toorn PP; Jager H; Heemsbergen W; Heijmen B; Pos F
    Lancet Oncol; 2016 Aug; 17(8):1061-1069. PubMed ID: 27339116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radiotherapy for stage B prostate cancer].
    Kobayashi T; Kawai T; Tachibana Y; Yamauchi T; Aizawa T
    Nihon Hinyokika Gakkai Zasshi; 1992 Sep; 83(9):1499-505. PubMed ID: 1434292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
    Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
    Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation therapy for the management of localized prostate carcinoma.
    Burmeister BH; Probert JC
    Aust N Z J Surg; 1991 Sep; 61(9):658-62. PubMed ID: 1877932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical radiotherapy in the management of carcinoma of the prostate.
    Jones DA; Eckert H; Smith PJ
    Br J Urol; 1982 Dec; 54(6):732-5. PubMed ID: 6817843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.
    Zumsteg ZS; Spratt DE; Romesser PB; Pei X; Zhang Z; Kollmeier M; McBride S; Yamada Y; Zelefsky MJ
    J Urol; 2015 Dec; 194(6):1624-30. PubMed ID: 26165583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late results of combined iodine-125 and external beam radiotherapy in carcinoma of prostate.
    Patel J; Worthen R; Abadir R; Weaver DJ; Weinstein S; Ross G
    Urology; 1990 Jul; 36(1):27-30. PubMed ID: 2368228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control.
    Syndikus I; Pickles T; Kostashuk E; Sullivan LD
    J Urol; 1996 Jun; 155(6):1983-6. PubMed ID: 8618303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Conformation radiotherapy of carcinoma of the prostate].
    Shimizu T; Tanaka Y; Takeshita N; Matsuda T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):993-1000. PubMed ID: 1508659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy.
    Puthawala AA; Syed AM; Austin PA; Cherlow JM; Perley JM; Shanberg AM; Sawyer DE; Ingram JE; Baghdassarian R; Wachs BH; Perley JE; Londrc A; Espinoza-Ferrel T
    Cancer; 2001 Oct; 92(8):2084-94. PubMed ID: 11596024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months.
    Ogawa K; Nakamura K; Sasaki T; Onishi H; Koizumi M; Shioyama Y; Araya M; Mukumoto N; Mitsumori M; Teshima T;
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):759-65. PubMed ID: 19327908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.
    Janoray G; Reynaud-Bougnoux A; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
    Cancer Radiother; 2016 Jun; 20(4):275-81. PubMed ID: 27342944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
    Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
    Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer.
    Haraf DJ; Rubin SJ; Sweeney P; Kuchnir FT; Sutton HG; Chodak GW; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):3-14. PubMed ID: 7642429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts.
    Hjälm-Eriksson M; Ullén A; Johansson H; Levitt S; Nilsson S; Kälkner KM
    Acta Oncol; 2017 Jan; 56(1):21-26. PubMed ID: 27882806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose escalation in image-guided, intensity-modulated radiotherapy of carcinoma prostate: initial experience in India.
    Swamy K; Sathiya Narayanan VK; Basu S; Maiya V; Achari R; Deshpande S; Bhangle J; Gupta KK; Babu N; Pawar S; Atre A; Balachandra K; Koppiker CB
    J Cancer Res Ther; 2009; 5(4):277-83. PubMed ID: 20160362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer: results of external irradiation.
    Reddy EK; Krishnan L; Giri S; Evans RG; Mebust WK; Weigel JW
    J Natl Med Assoc; 1993 Feb; 85(2):109-12. PubMed ID: 8441185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated results of high-dose rate brachytherapy and external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition.
    Pellizzon AC; Salvajoli J; Novaes P; Maia M; Fogaroli R
    Int Braz J Urol; 2008; 34(3):293-301. PubMed ID: 18601759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer.
    Kotecha R; Yamada Y; Pei X; Kollmeier MA; Cox B; Cohen GN; Zaider M; Zelefsky MJ
    Brachytherapy; 2013; 12(1):44-9. PubMed ID: 22831750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.